DRUG · NASDAQ
Bright Minds Biosciences (DRUG) Stock Price & Fundamentals
Bright Minds Biosciences (DRUG) closed at $534.77 on Oct 9, 2026, up 0.22% from the previous close of $533.61.
Share price, past year
1Y +9.20%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $534.77 |
| Sep 30, 2026 | $536.05 |
| Aug 31, 2026 | $531.95 |
| Jul 31, 2026 | $520.90 |
| Jun 30, 2026 | $523.98 |
| May 29, 2026 | $516.55 |
| Apr 30, 2026 | $511.75 |
| Mar 31, 2026 | $489.72 |
| Feb 27, 2026 | $511.10 |
| Jan 30, 2026 | $495.69 |
| Dec 31, 2025 | $528.42 |
| Nov 28, 2025 | $529.53 |
| Oct 31, 2025 | $503.19 |
Key statistics
- 52-week range
- $482.33 – $538.87
Financials
Bright Minds Biosciences reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- Bright Minds Biosciences Inc.
- Ticker
- DRUG
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 400 N Aberdeen St Suite 900, Chicago, IL 60642
- Incorporated in
- A1
- Fiscal year ends
- September
- SEC CIK
- 0001827401
Frequently asked questions
What is Bright Minds Biosciences's stock price?
Bright Minds Biosciences (DRUG) closed at $534.77 on Oct 9, 2026, up 0.22% from the previous close of $533.61.
Sources and methodology
Fundamentals come from Bright Minds Biosciences Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures